Product peg-derivatives -peptide-pegs

Home > products > peg-derivatives > peptide-pegs

Catalog	name	Description	price
R-M2-9545	Cholesterol-PEG2000-RVG29PPP(D-RVG29)	Cholesterol-PEG2000-RVG29PPP(D-RVG29) represents a promising strategy for targeted therapeutics, primarily in neurological contexts.The conjugate can encapsulate and deliver various therapeutic agents (small molecules, peptides, nucleic acids) directly to neuronal tissues. Given the ability of RVG29 to cross the blood-brain barrier, this conjugate could be used to treat neurodegenerative diseases (like Alzheimer’s or Parkinson’s disease) or CNS tumors.Can potentially be utilized to deliver genetic materials (such as siRNA or plasmids) into neural cells to address genetic disorders or modulate gene expression.Potential applications in neuroimaging or as a vector for imaging agents to enhance the detection of CNS disorders.	price>
R-M2-9546	DMG-PEG2000-RVG29PPP(D-RVG29)	The DMG-PEG2000-RVG29PPP(D-RVG29) construct represents a sophisticated approach to enhance drug delivery systems, particularly for targeting the central nervous system. The integration of DMG with PEG and RVG29 allows for improved solubility and specific targeting abilities, making this construct suitable for a wide range of therapeutic applications in CNS disorders. Potential use in imaging techniques for neurological conditions, acting as a vector for radiolabeled compounds or contrast agents to enhance visualization in medical imaging.	price>
R-M2-9547	Cholesterol-PEG-CD38(ARGDYYGSNSLDYW)	The Cholesterol-PEG-CD38(ARGDYYGSNSLDYW) construct represents a sophisticated approach for drug delivery, combining the cellular targeting capabilities of a peptide with the solubility-enhancing properties of PEG and the membrane fusion properties of cholesterol. Its design allows for specific applications in therapeutic and diagnostic fields, primarily within oncology and immunology.Cholesterol-PEG-CD38(ARGDYYGSNSLDYW)could be employed to deliver chemotherapeutic agents specifically to tumor cells expressing CD38, allowing for localized therapy with reduced systemic toxicity.It can be used in the formulation of vaccines where targeting immune cells is necessary to enhance vaccine efficacy.	price>
R-M2-9548	DMG-PEG-CD38	DMG-PEG-CD38/DMG-PEG-ARGDYYGSNSLDYW is a multifunctional conjugate that utilizes the benefits of lipid modification, PEGylation, and a targeting peptide sequence to improve the delivery of therapeutic agents. Targeting peptides, in particular, are powerful tools in modern therapeutic strategies, enabling the development of more effective and less toxic treatment options. Further development and optimization of this conjugate could advance its use in targeted drug delivery, diagnostic applications, or therapeutic innovations.	price>
R-M2-9555	DMG-PEG2000-WMVLPWLPGTLDGGSGCR	DMG-PEG2000-WMVLPWLPGTLDGGSGCR is a multifunctional compound comprising PEG for improved pharmacokinetics, a DMG component for solubility and stability, and a specific peptide sequence for targeting or therapeutic action. This combination of elements makes it suitable for research and development in the fields of biomedicine, drug delivery, and peptide therapeutics.	price>
R-M2-9556	Chol-PEG2000-WMVLPWLPGTLDGGSGCR	The Chol-PEG2000-WMVLPWLPGTLDGGSGCR compound is a versatile conjugate combining cholesterol, polyethylene glycol, and a peptide with potential applications in drug delivery, targeting, immunotherapy, and nanotechnology.The Chol-PEG2000 moiety in this conjugate may enhance the formulation’s ability to encapsulate hydrophobic drugs (due to the cholesterol) and improve solubility and circulation in biological systems (due to PEG). This conjugate could be particularly useful in liposomal formulations or micellar systems for drug delivery.The peptide sequence (WMVLPWLPGTLDGGSGCR) may act as a targeting ligand, allowing the conjugate to bind specifically to cell types, receptors, or tissues of interest.	price>
R-M2-9557	DMG-PEG2000-WEAALAEALAEALAEHLAEALAEALEALAA	The DMG-PEG2000-WEAALAEALAEALAEHLAEALAEALEALAA compound is likely designed for use in advanced drug delivery systems or formulations aimed at improving the solubility, stability, and targeting capabilities of therapeutic agents. Its specific applications may span across targeted therapies, vaccine development, and potentially in creating multifunctional nanoparticles.	price>
R-M2-9558	Chol-PEG2000-WEAALAEALAEALAEHLAEALAEALEALAA	Chol-PEG2000-WEAALAEALAEALAEHLAEALAEALEALAA is likely engineered for applications in drug and gene delivery systems while potentially providing targeted therapeutic capabilities. Its composition suggests enhanced biocompatibility and stability, as well as the capacity for specific cellular targeting due to the peptide inclusion. These properties make it suitable for diverse biomedical applications, including targeted therapies, vaccine development, and more.	price>
R-M2-9560	Chol-PEG2K-GPLVRG-mPEG5K	Chol-PEG2K-GPLVRG-mPEG5K/Cholesterol-PEG2K-GPLVRG-mPEG5K/mPEG5K-GPLVRG-PEG2K-Chol could be designed to form nanoparticles for targeted drug delivery, especially for cancer or other therapies where increased specificity and reduced toxicity are desired.	price>
R-M2-9572	Ac-RVRRCK-PEG5K-SH	Ac-RVRRCK-PEG5K-SH/Ac-RVRRCK-PEG5K-thiol is a peptide modified PEG compound.The PEGylation can enhance solubility and stability in circulation, while the RVRRCK sequence might facilitate cellular uptake.The free thiol (-SH) allows for conjugation to other molecules, like drugs, imaging agents, or nanomaterials, through thiol-maleimide chemistry, among other approaches.The peptide may be used in the development of synthetic constructs that require targeted delivery or penetration into cells.If incorporated into liposome formulations, it could be used to examine the effects of cell-penetrating peptides on liposome stability and encapsulation efficiency.	price>

...